S-Ethylisothiourea Hydrobromide CAS 1071-37-0 Puritas >98.0% Ensitrelvir (S-217622) Intermedia COVID-19
Commercial Supple Ensitrelvir (S-217622) Intermedia:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl) -1-methyl-1H-1,2,4-triazolum hydrochloridum CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8
Nomen chemicum | S-Ethylisothiourea Hydrobromide |
CAS Number | 1071-37-0 |
CATTUS Number | RF-PI1502 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C3H8N2S·HBr |
M. Pondus | 185.08 |
Liquescens punctum | 79.0~81.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | White to Fere Alba pulveris ad Crystal |
Puritas | >98.0% |
Damnum in Siccatio | <0.50% |
una immunditia | <0.50% |
Totalis immunditias | <2.00% |
Metalla gravia (ut Pb) | <20ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Pharmaceutical Intermedia;Medium Ensitrelvir (S-217622). |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
S-Ethylisothiourea hydrobromida (CAS: 1071-37-0) uti potest ut synthesis organica intermedia et pharmaceutica media.S-Ethylisothiourea Hydrobromide adhiberi potest in synthesi Ensitrelvir (S-217622).Ensitrelvir (S-217622) est primus viva voce activa inhibitor non covalens, non-peptidicus, SARS-CoV-2 3CL protease inhibitor (IC50=13 nM).